Change in the Board of Directors of Egetis Therapeutics

MARKN.

Stockholm, Sweden, October 4, 2024. Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (Nasdaq Stockholm: EGTX), today announced that Peder Walberg has decided to resign from the Board of Directors with immediate effect, to focus on his role as a major shareholder of the Company. Peder will continue to support the Company in his current operational role as a consultant to the Company.

Mats Blom, Chairman of the Board of Directors, said: “I would like to thank Peder for his invaluable contributions to the Board of Egetis and I’m pleased that he will continue to support the Company as a major shareholder and consultant.”

For further information, please contact:

Mats Blom, Chairman of the Board of Directors

+46 761 45 70 90

Datum 2024-10-04, kl 08:00
Källa MFN
Ungdomsdeal - 200 kr ! Just nu får alla nya kunder mellan 18 och 25 år 200 kr gratis när man skapar konto på Nordnet, insatt i fonden Nordnet One Balanserad. Bra läge att testa Nordnet!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet